Baxter International Inc. (NYSE:BAX) Q2 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to Baxter International's Second Quarter 2023 Earnings Conference Call.
Stay updated with breaking news from Advanced Surgery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good morning, ladies and gentlemen, and welcome to Baxter International's Second Quarter 2023 Earnings Conference Call.
The weather outside may have been uninspiring but it was all warmth and aroha inside the University of Otago, Christchurch campus last Friday as staff and students gathered for the annual Matariki staff awards alongside a new event - a Matariki Market Day.
Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the launch of PERCLOT Absorbable Hemostatic Powder in the U.S. PERCLOT is a passive, absorbable hemostatic powder that is ready to use and designed for patients with intact coagulation to address mild bleeding ...
Marks first passive hemostat for Baxter in the U.S. market, broadening portfolio offering to include a full range of active and passive hemostatic products ...
Baxter (NYSE: BAX) announced today that it has launched the PerClot absorbable hemostatic powder in the U.S.